Fig. 9

Subgroup analysis of effects of SGLT-2 inhibitors on hypovolemia. (A) Subgroup analysis based on type of heart failure. (B) Subgroup analysis based on the type of SGLT-2 inhibitors. (C) Subgroup analysis based on patient age
Subgroup analysis of effects of SGLT-2 inhibitors on hypovolemia. (A) Subgroup analysis based on type of heart failure. (B) Subgroup analysis based on the type of SGLT-2 inhibitors. (C) Subgroup analysis based on patient age